Business
AstraZeneca vaccine: Two more countries restrict vaccine rollout over blood clot concerns – The Australian Financial Review
An arm’s length investigation is needed to sort out the blood clot issue plaguing the AstraZeneca vaccine, say medical experts.
It also applied to those with heparin-induced thrombocytopenia, who have an adverse immune reaction to the drug heparin and their platelet function is affected.
ATAGI reassured people there was no evidence of risk for those with a history of other clotting conditions and recommended the jabs for a list for conditions including deep venous thrombosis, a clot in the lung and low platelets.
The vaccine was also recommended for people with risk factors for clotting: such as smoking or using oral contraceptives;…
-
General16 hours agoDeepfake AI ad featuring WA Premier Roger Cook prompts latest scam warning
-
General15 hours agoCommunity devastated after freight train kills one-year-old girl near Narrabri
-
General13 hours agoPolice allowed neo-Nazi protest outside NSW parliament
-
Business23 hours agoWhat can investors expect from ANZ results on Monday?